跳至主要内容
临床试验/NCT01867476
NCT01867476已完成不适用

Adherence Monitoring For Substance Abuse Clinical Trials

California Pacific Medical Center Research Institute1 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2013年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
8
试验地点
1
主要终点
Variance between urine and oral fluid riboflavin levels when specimens are obtained 'as usual' and after a one-hour inter specimen interval

研究概览

简要总结

The purpose of this study is to determine the feasibility and accuracy of an automated adherence monitoring system, and to compare the variance between urine and oral fluid riboflavin levels when specimens are obtained 'as usual' and after a one-hour inter specimen interval.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female, aged 18 to 60
  • Ability to give informed consent.
  • Be willing and able to use the study-provided phone for taking and transmitting capsule photos.

排除标准

  • Unwilling or unable to use a cell phone.
  • Any medical, psychiatric, or other condition that, in the opinion of the investigator, would preclude safe, consistent, or useful participation in the study.

结局指标

主要结局

Variance between urine and oral fluid riboflavin levels when specimens are obtained 'as usual' and after a one-hour inter specimen interval

时间窗: + 1, 2, 3, 4, 6 hours post dose

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

John Mendelson, MD

Senior Scientist

California Pacific Medical Center Research Institute

研究点 (1)

Loading locations...

相似试验